NCT05872893 2023-07-21
Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone
Immune Oncology Research Institute
Phase 3 Unknown
Clinical Trials
7 trialsNCT00324467 2021-07-22
LYTPET
British Columbia Cancer Agency
Phase 2 Unknown
NCT03606369 2018-07-30
Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.
Instituto Nacional de Cancerologia de Mexico
Phase 2/3 Unknown
NCT01913990 2017-01-30
ER11-02
Ottawa Hospital Research Institute
Phase 4 Unknown
NCT02979548 2017-01-25
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
All India Institute of Medical Sciences
Phase 3 Unknown
NCT02234466 2014-09-09
Preoperative Oral Dexamethasone to Improve Recovery After Surgery
University of Manitoba
Phase 2 Unknown
NCT01536691 2012-10-03
ROAD
Hallym University Medical Center
Phase 3 Unknown